SCPX:NYE-Scorpius Holdings Inc (USD)

COMMON STOCK | Biotechnology |

Last Closing

USD 0.176

Change

-0.01 (-5.33)%

Market Cap

N/A

Volume

0.44M

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-05-07 )

Largest Industry Peers for Biotechnology

Symbol Name Price(Change) Market Cap
NVO Novo Nordisk A/S

N/A

USD 567.03B
BHVN Biohaven Pharmaceutical Holdin..

N/A

USD 3.30B
HTD John Hancock Tax Advantaged Di..

N/A

USD 2.41B
DNA Ginkgo Bioworks Holdings

N/A

USD 1.68B
RCUS Arcus Biosciences Inc

N/A

USD 1.60B
NUVB Nuvation Bio Inc

N/A

USD 0.80B
ADCT ADC Therapeutics SA

N/A

USD 0.39B
PGP PIMCO Global StocksPLUS & Inco..

N/A

USD 0.32B
ATNM Actinium Pharmaceuticals Inc

N/A

USD 0.29B
CYBN Cybin Inc

N/A

USD 0.28B

ETFs Containing SCPX

XSD SPDR® S&P Semiconductor .. 3.93 % 0.35 %

N/A

USD 1.44B
XSDX:LSE Xtrackers ShortDAX Daily .. 3.91 % 0.00 %

N/A

USD 0.19B
DXSN:F Xtrackers - ShortDAX Dail.. 3.91 % 0.00 %

N/A

USD 0.19B
DXSN:XETRA Xtrackers - ShortDAX Dail.. 3.91 % 0.00 %

N/A

USD 0.21B
XITK SPDR® FactSet Innovative.. 1.83 % 0.45 %

N/A

USD 0.12B
ISMD Inspire Small/Mid Cap Imp.. 0.26 % 0.62 %

N/A

USD 0.19B

Market Performance

  Market Performance vs. Industry/Classification (Biotechnology) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Trailing 12 Months  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) N/A N/A N/A N/A N/A
Risk Adjusted Return N/A N/A N/A N/A N/A
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:

There is nothing we particularly dislike